A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211) Meeting Abstract
| Authors: | Kunz, P. L.; Catalano, P. J.; Nimeiri, H. S.; Fisher, G. A.; Longacre, T. A.; Schrijver, I.; Reidy, D. L.; Strosberg, J. R.; O'Dwyer, P. J.; Benson, A. |
| Abstract Title: | A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: A trial of the ECOG-ACRIN Cancer Research Group (E2211) |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036904753 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.tps4145 |
| Notes: | Meeting Abstract: TPS4145 -- Source: Wos |
